Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study

We sought to identify novel pharmacogenomic markers for HDL-C response to atenolol in participants with mild to moderate hypertension. We genotyped 768 hypertensive participants from the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study on the Illumina HumanCVD Beadchip. During P...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonough, Caitrin W., Gillis, Nancy K., Alsultan, Abdullah, Chang, Shin-Wen, Kawaguchi-Suzuki, Marina, Lang, Jason E., Shahin, Mohamed Hossam A., Buford, Thomas W., El Rouby, Nihal M., Sá, Ana C.C., Langaee, Taimour Y., Gums, John G., Chapman, Arlene B., Cooper-DeHoff, Rhonda M., Turner, Stephen T., Gong, Yan, Johnson, Julie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792156/
https://www.ncbi.nlm.nih.gov/pubmed/24116192
http://dx.doi.org/10.1371/journal.pone.0076984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792156/
https://www.ncbi.nlm.nih.gov/pubmed/24116192
http://dx.doi.org/10.1371/journal.pone.0076984

Ejemplares similares